Stay updated on Long-term Baricitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Long-term Baricitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Long-term Baricitinib in Atopic Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedA new revision label, Revision: v3.4.2, is now shown. The page also removes the previous funding-status notice and the earlier Revision: v3.4.1 reference.SummaryDifference0.1%

- Check8 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's status. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check15 days agoChange DetectedShow glossary option added; Study Record Dates now displays 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the previous QC label and removing 'No FEAR Act data'.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed. This appears to be a metadata/version update and does not modify the study content, eligibility criteria, or outcomes on the Study Details page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedExpanded the study's site network by adding numerous new locations (Buenos Aires; sites across Australia, Europe, the Americas, and Asia). The changes reorganize the Locations data under a Locations header and update the revision to v3.3.3.SummaryDifference3%

- Check79 days agoChange DetectedAdded a PubMed auto-fill publication note with a new Revision: v3.3.2 and removed the older PubMed publications note (Revision: v3.2.0).SummaryDifference0.6%

Stay in the know with updates to Long-term Baricitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Baricitinib in Atopic Dermatitis Clinical Trial page.